These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17551441)

  • 1. The management of lipohypertrophy in diabetes care.
    Hambridge K
    Br J Nurs; 2007 May 10-23; 16(9):520-4. PubMed ID: 17551441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors.
    Vardar B; Kizilci S
    Diabetes Res Clin Pract; 2007 Aug; 77(2):231-6. PubMed ID: 17303282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodules of fibrocollagenous scar tissue induced by subcutaneous insulin injections: a cause of poor diabetic control.
    Wallymahmed ME; Littler P; Clegg C; Haqqani MT; Macfarlane IA
    Postgrad Med J; 2004 Dec; 80(950):732-3. PubMed ID: 15579616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in depression, treatment satisfaction and injection behaviour in adults with type 1 diabetes and different degrees of lipohypertrophy.
    Hernar I; Haltbakk J; Broström A
    J Clin Nurs; 2017 Dec; 26(23-24):4583-4596. PubMed ID: 28295770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipohypertrophy].
    Müssig K; Gallwitz B
    Dtsch Med Wochenschr; 2006 Aug; 131(33):1807-8. PubMed ID: 16902904
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipohypertrophy--a complication of insulin injections.
    de Villiers FP
    S Afr Med J; 2005 Nov; 95(11):858-9. PubMed ID: 16344882
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of Insulin Injection Technique: Examination of Current Issues and Recommendations.
    Spollett G; Edelman SV; Mehner P; Walter C; Penfornis A
    Diabetes Educ; 2016 Aug; 42(4):379-94. PubMed ID: 27216036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Errors in insulin treatment management and risk of lipohypertrophy.
    Pozzuoli GM; Laudato M; Barone M; Crisci F; Pozzuoli B
    Acta Diabetol; 2018 Jan; 55(1):67-73. PubMed ID: 29098390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 1 diabetes: identifying and evaluating patient injection technique.
    Spray J
    Br J Nurs; 2009 Oct 8-21; 18(18):1100-5. PubMed ID: 19966727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipohypertrophy Monitoring Study (LIMO): Effect of single use of 4 mm pen needles combined with education on injection site rotation on glycaemic control: Confirmation of an unpleasant truth.
    Bochanen N; Decochez K; Heleu E; Cuypers J; Vercammen C; Coremans P; Vanhaverbeke G; Shadid S; Keymeulen B; Bolsens N; De Block C
    Diabet Med; 2022 Jan; 39(1):e14672. PubMed ID: 34407260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin application techniques in adult patients with diabetes].
    Pelcl T; Prázný M
    Vnitr Lek; 2016; 62(6):486-90. PubMed ID: 27485848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical signs for the general dental practitioner. Case 74. Lipohypertrophy.
    Bain S
    Dent Update; 2010 May; 37(4):268. PubMed ID: 20527502
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes.
    Blanco M; Hernández MT; Strauss KW; Amaya M
    Diabetes Metab; 2013 Oct; 39(5):445-53. PubMed ID: 23886784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetes, injection technic and patient education].
    Mosnier-Pudar H
    Soins; 2010 May; (745):17. PubMed ID: 20509482
    [No Abstract]   [Full Text] [Related]  

  • 15. Poor glycaemic control caused by insulin induced lipohypertrophy.
    Chowdhury TA; Escudier V
    BMJ; 2003 Aug; 327(7411):383-4. PubMed ID: 12919996
    [No Abstract]   [Full Text] [Related]  

  • 16. Switching from an oral regimen to insulin in diabetes.
    Perry M
    Community Nurse; 2000 May; 6(4):27-8. PubMed ID: 12778520
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of lipohypertrophy.
    Kalra S; Kumar A; Gupta Y
    J Pak Med Assoc; 2016 Jul; 66(7):910-1. PubMed ID: 27427150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors.
    Hauner H; Stockamp B; Haastert B
    Exp Clin Endocrinol Diabetes; 1996; 104(2):106-10. PubMed ID: 8740933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog).
    Roper NA; Bilous RW
    Diabet Med; 1998 Dec; 15(12):1063-4. PubMed ID: 9868982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating innovative tools into the management of type 2 diabetes to improve patient self-management.
    Kruger DF
    J Am Acad Nurse Pract; 2008 Nov; 20 Suppl 1():17-20. PubMed ID: 19402256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.